On October 27, Suzhou Municipal Party Secretary Fan Bo met with AbbVie Global Executive Vice President Nicholas Donoghue and his entourage. On behalf of the municipal party committee and municipal government, Fan Bo welcomed Nicholas Donoghue and his entourage to Suzhou and thanked AbbVie for their concern and support for Suzhou's development. He said that Suzhou is an important central city in eastern China, and it is also a “double-sided embroidery” city where ancient charm and modern style intersect brilliantly. Currently, we are focusing on establishing a strong industrial market, and opening up the market, firmly grasping strategic grippers such as the same urbanization development in key areas of Shanghai and Suzhou, the key fulcrum of the Shanghai International Science and Technology Innovation Center, and the National New Industrialization Demonstration Zone, and focusing on building a “1030” industrial system, cultivating and expanding “10+10” key industries, and developing new quality productivity according to local conditions. AbbVie is the world's leading research biopharmaceutical company. It has continued to deepen its clinical research layout in Suzhou in recent years, fully demonstrating its high recognition of Suzhou's innovative ecology and biomedical industry development. We hope that AbbVie will continue to care about and support the development of Suzhou, increase its layout, and deepen innovation cooperation. Suzhou will continue to expand a high level of openness to the outside world, further carry out the “Three Services” special campaign, build a “responsive, closed loop” business environment brand, and provide enterprises with the best service guarantee.
Zhitongcaijing · 2d ago
Share
Listen to the news
On October 27, Suzhou Municipal Party Secretary Fan Bo met with AbbVie Global Executive Vice President Nicholas Donoghue and his entourage. On behalf of the municipal party committee and municipal government, Fan Bo welcomed Nicholas Donoghue and his entourage to Suzhou and thanked AbbVie for their concern and support for Suzhou's development. He said that Suzhou is an important central city in eastern China, and it is also a “double-sided embroidery” city where ancient charm and modern style intersect brilliantly. Currently, we are focusing on establishing a strong industrial market, and opening up the market, firmly grasping strategic grippers such as the same urbanization development in key areas of Shanghai and Suzhou, the key fulcrum of the Shanghai International Science and Technology Innovation Center, and the National New Industrialization Demonstration Zone, and focusing on building a “1030” industrial system, cultivating and expanding “10+10” key industries, and developing new quality productivity according to local conditions. AbbVie is the world's leading research biopharmaceutical company. It has continued to deepen its clinical research layout in Suzhou in recent years, fully demonstrating its high recognition of Suzhou's innovative ecology and biomedical industry development. We hope that AbbVie will continue to care about and support the development of Suzhou, increase its layout, and deepen innovation cooperation. Suzhou will continue to expand a high level of openness to the outside world, further carry out the “Three Services” special campaign, build a “responsive, closed loop” business environment brand, and provide enterprises with the best service guarantee.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending